Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 Mutations
Abroad (travel likely)RecruitingPHASE1
Conditions
Gliomas Harboring IDH1 and/or IDH2 Mutations
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Huashan Hospital affiliated to Fudan University, Shanghai, Shanghai Municipality, China
Study leads
Jinsong Wu
Principal Investigator
Huashan Hospital
Bo Zhang
Study Director
Hutchmed